Abstract
Comparative analysis of mortality of critically ill patients with infections due to carbapenem-resistant Gram-negative bacilli treated with ceftazidimeavibactam or polymyxin B
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have